by Ali-Maree | Apr 28, 2022 | Patients |
Key points The misuse of prescription opioids for chronic pain relief has resulted in high rates of addiction and overdose. New research indicates that medical cannabis can be an effective painkiller and even a preferred agent for many with chronic pain. The medical...
by Ali-Maree | Mar 18, 2022 | Patients |
Visit the link below to see the full story from ABC News. Full Story: https://www.abc.net.au/news/health/2022-03-12/medicinal-cannabis-prescriptions-grow-as-access-becomes-easier/100901244
by Ali-Maree | Mar 18, 2022 | Members Only |
Study conducted at the University of Western Australia Centre for Sleep Science and The Alfred Hospital, has shown their phase II clinical trial of Incannex Healthcare’s novel cannabinoid combination IHL-42X led to a substantial reduction in obstructive sleep apnea...
by Ali-Maree | Mar 18, 2022 | Members Only |
The American Journal of Medicine has published a study of 5115 people (men and women), with 35,654 examinations over 30 years. The study concluded that recent current cannabis use was associated with lower resting heart rate. The findings appeared to be transient, as...
by Ali-Maree | Mar 18, 2022 | Patients |
Cann Group have received the Office of Drug Control (ODC) green light to commence commercial cultivation at its new manufacturing facility near Mildura in North West Victoria. The permit allows for cultivation and production of medicinal cannabis and research...
